The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis
International Journal of Molecular Sciences · 19.04.2025 · 26 (8) · 3868
DOI: 10.3390/ijms26083868 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.04.2025. Verfasst von Agnieszka Kimak-Pielas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Teaching Hospital No 2, 90-549 Lodz, Poland. Hauptthemen laut MEDLINE: Psoriasis, Neutrophils, Lymphocytes, Blood Platelets. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Plaque psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the formation of thick, scaly plaques. The disease is driven by dysregulation of the immune response, primarily involving T-helper cells, which create a persistent inflammatory environment. In recent years, several biomarkers reflecting systemic inflammation have been identified, including indices derived from a complete blood count, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and Systemic Immune-Inflammation Index (SII). The aim of our study was to explore the role of these markers in patients with psoriasis undergoing biological treatment. Medical records of 159 patients with plaque psoriasis receiving biologics were retrospectively reviewed. The NLR, PLR, and SII values were calculated from the hemograms of the patients. Additionally, demographic and psoriasis severity data were analyzed. During the 18-month follow-up, the mean NLR, PLR, SII, and CRP values were significantly decreased in comparison to the baseline (p < 0.05). No significant differences between anti-TNF, anti-IL-12/23, anti-IL-17, and anti-IL-23 drugs were identified (p > 0.05). The initial values of NLR, PLR, and SII were positively correlated with psoriasis severity. No relationship between the analyzed biomarkers and age, sex, psoriasis duration, and prior exposure to biological drugs was identified. CBC-derived biomarkers may be useful for monitoring inflammation reduction in psoriasis patients treated with biological drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Teaching Hospital No 2, 90-549 Lodz, Poland.
- Department of Dermatology, Medical University of Lodz, 90-647 Lodz, Poland.
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland.
- Department of Medical Informatics and Statistics, Medical University of Lodz, 90-645 Lodz, Poland.
ORCID-Profile: Agnieszka Kimak-Pielas, Ewa Robak, Agnieszka Żebrowska
Förderung
- Medical University of Lodz
Zitieren
APA
Kimak-Pielas, A., Robak, E., Zajdel, R., & Żebrowska, A. (2025). The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis. International Journal of Molecular Sciences, 26(8), 3868. https://doi.org/10.3390/ijms26083868
Vancouver
Kimak-Pielas A, Robak E, Zajdel R, Żebrowska A. The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis. International Journal of Molecular Sciences. 2025;26(8):3868. doi:10.3390/ijms26083868
BibTeX
@article{KimakPielas2025,
author = {Kimak-Pielas, Agnieszka and Robak, Ewa and Zajdel, Radosław and Żebrowska, Agnieszka},
title = {The Relationship Between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Markers and Response to Biological Therapy in Patients with Psoriasis},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3868},
doi = {10.3390/ijms26083868}
}
EUVIMED